On this show we drink scotch and answer questions about sentiment, bad news, CCP’s Operating Cash Flow, the sell price for TRS and investing in borderline star stocks.
We chat about a couple of recent articles (see below) and then talk about Tony’s recent alerts involving LYL and KCN. Next we run AMI through the QAV Checklist and answer some questions about why the “buy list” is so large and whether or not we should/could shorten it using Stock Doctor filters.
Another 90 minute Club episode this week! Investor, “unemployed shoe salesman” and new board member of The Australian Shareholders Association, Steven Mabb, joins us to talk about the value that the ASA brings to retail shareholders and tries to sell Tony on becoming a member. Then we get into this week’s questions, including how long Tony waits before selling a “non-performing” stock; whether or not TK would sell a stock in his portfolio because it’s QAV score dropped below 0.1; whether or not TK would wait to see what the US market does before he buys something locally; and whether or not he has tried applying Benjamin Graham’s formula for capitalization rates for growth stocks.
On this episode we talk about why we are not trying to compete with APT investors; Tony’s recent stock buys and analysis; how he uses his “watch list” and why we’ve changed its name to the “buy list”; we we’re still manually calculating the price-to-cash ratio instead of using Stock Doctor’s figure; improved wording on how to draw a three point trend SELL line; and why sometimes a stock with great numbers might have a falling knife.
Tony’s stock broker of 25+ years, Alex Hay, a partner at broking firm EL&C Baillieu, joins us again today to talk about the different kinds of buy & sell orders and how to use them. Outside of that, Tony and I also talk about our dummy portfolio, which made it back into the black, and some excel formula errors we’ve picked up recently in the checklist.
Here’s our recent chat with Tobias Carlisle, author of several books on value investing, including ‘The Acquirer’s Multiple: How the Billionaire Contrarians of Deep Value Beat the Market’, and the managing director of The Aquirers Fund.